Lundberg, I. E. et al. Idiopathic inflammatory myopathies. Nat. Rev. Dis. Prim. 7, 86 (2021).

Article  PubMed  Google Scholar 

McHugh, N. J. & Tansley, S. L. Autoantibodies in myositis. Nat. Rev. Rheumatol. 14, 290–302 (2018).

Article  CAS  PubMed  Google Scholar 

Sato, S. et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 52, 1571–1576 (2005).

Article  CAS  PubMed  Google Scholar 

Sontheimer, R. D. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J. Am. Acad. Dermatol. 46, 626–636 (2002).

Article  PubMed  Google Scholar 

Mammen, A. L., Allenbach, Y., Stenzel, W. & Benveniste, O. 239th ENMC International Workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018. Neuromuscul. Disord. 30, 70–92 (2020).

Article  PubMed  Google Scholar 

Muro, Y., Sugiura, K., Hoshino, K., Akiyama, M. & Tamakoshi, K. Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan. Arthritis Res. Ther. 13, R214 (2011).

Article  CAS  PubMed  Google Scholar 

Nishina, N., Sato, S., Masui, K., Gono, T. & Kuwana, M. Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease. RMD Open. 6, e001202 (2020).

Article  PubMed  Google Scholar 

So, H. et al. Seasonal effect on disease onset and presentation in anti-MDA5 positive dermatomyositis. Front. Med. 9, 837024 (2022).

Article  Google Scholar 

Toquet, S. et al. The seasonality of dermatomyositis associated with anti-MDA5 antibody: an argument for a respiratory viral trigger. Autoimmun. Rev. 20, 102788 (2021).

Article  CAS  PubMed  Google Scholar 

Tonutti, A. et al. Anti-MDA5 antibody linking COVID-19, type I interferon, and autoimmunity: a case report and systematic literature review. Front. Immunol. 13, 937667 (2022).

Article  CAS  PubMed  Google Scholar 

Kitajima, T. et al. Antimelanoma differentiation-associated gene 5 antibody-positive interstitial lung disease after vaccination with COVID-19 mRNA vaccines. J. Rheumatol. 49, 1158–1162 (2022).

Article  CAS  PubMed  Google Scholar 

Kondo, Y. et al. COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still’s disease. Clin. Exp. Rheumatol. 39, 631–638 (2021).

Article  PubMed  Google Scholar 

Jin, Q. et al. Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti‐MDA5‐positive dermatomyositis. J. Intern. Med. 293, 494–507 (2023).

Article  CAS  PubMed  Google Scholar 

Fiorentino, D., Chung, L., Zwerner, J., Rosen, A. & Casciola-Rosen, L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J. Am. Acad. Dermatol. 65, 25–34 (2011).

Article  PubMed  Google Scholar 

Kurtzman, D. J. B. & Vleugels, R. A. Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: a concise review with an emphasis on distinctive clinical features. J. Am. Acad. Dermatol. 78, 776–785 (2018).

Article  CAS  PubMed  Google Scholar 

Combalia, A., Giavedoni, P., Tamez, L., Grau-Junyent, J. M. & Mascaró, J. M. Jr. Bosentan for cutaneous ulcers in anti-MDA5 dermatomyositis. JAMA Dermatol. 154, 371–373 (2018).

Article  PubMed  Google Scholar 

Min, H. K. et al. Refractory digital ulcers treated by botulinum toxin and endothelin receptor-1 antagonist in anti-MDA5-antibody-positive dermatomyositis. J. Clin. Neurol. 16, 160 (2020).

Article  PubMed  Google Scholar 

Narang, N. S., Casciola-Rosen, L., Li, S., Chung, L. & Fiorentino, D. F. Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease. Arthritis Care Res. 67, 667–672 (2015).

Article  CAS  Google Scholar 

Chanprapaph, K., Udompanich, S., Visessiri, Y., Ngamjanyaporn, P. & Suchonwanit, P. Nonscarring alopecia in systemic lupus erythematosus: a cross-sectional study with trichoscopic, histopathologic, and immunopathologic analyses. J. Am. Acad. Dermatol. 81, 1319–1329 (2019).

Article  PubMed  Google Scholar 

Yang, H. et al. Differential clinical associations of anti–nuclear matrix protein 2 autoantibodies in patients with idiopathic inflammatory myopathies. Arthritis Rheumatol. 70, 1288–1297 (2018).

Article  CAS  PubMed  Google Scholar 

Hall, J. C. et al. Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum. Arthritis Care Res. 65, 1307–1315 (2013).

Article  CAS  Google Scholar 

Valenzuela, A., Chung, L., Casciola-Rosen, L. & Fiorentino, D. Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis. JAMA Dermatol. 150, 724–729 (2014).

Article  PubMed  Google Scholar 

Rathore, U., Haldule, S. & Gupta, L. Psoriasiform rashes as the first manifestation of anti-MDA5 associated myositis. Rheumatology 60, 3483–3483 (2021).

Article  PubMed  Google Scholar 

Nombel, A., Fabien, N. & Coutant, F. Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies. Front. Immunol. 12, 773352 (2021).

Article  CAS  PubMed  Google Scholar 

Xie, H. et al. Risk factors for mortality in patients with anti-MDA5 antibody-positive dermatomyositis: a meta-analysis and systematic review. Semin. Arthritis Rheum. 62, 152231 (2023).

Article  CAS  PubMed  Google Scholar 

Gono, T. et al. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology 49, 1713–1719 (2010).

Article  CAS  PubMed  Google Scholar 

Chen, F., Wang, D., Shu, X., Nakashima, R. & Wang, G. Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis. Rheumatol. Int. 32, 3909–3915 (2012).

Article  CAS  PubMed  Google Scholar 

Ceribelli, A. et al. Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis. Clin. Exp. Rheumatol. 32, 891–897 (2014).

PubMed  Google Scholar 

Chen, Z. et al. Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis. Arthritis Care Res. 65, 1316–1324 (2013).

Article  CAS  Google Scholar 

Zuo, Y. et al. Clinical significance of radiological patterns of HRCT and their association with macrophage activation in dermatomyositis. Rheumatology 59, 2829–2837 (2020).

Article  CAS  PubMed  Google Scholar 

Chino, H. et al. Radiological and pathological correlation in anti-MDA5 antibody-positive interstitial lung disease: rapidly progressive perilobular opacities and diffuse alveolar damage. Intern. Med. 55, 2241–2246 (2016).

Article  PubMed  Google Scholar 

Chino, H. et al. Interstitial lung disease with anti-melanoma differentiation-associated protein 5 antibody: rapidly progressive perilobular opacity. Intern. Med. 58, 2605–2613 (2019).

Article  PubMed  Google Scholar 

Chen, X. et al. Clinical, radiological and pathological features of anti-MDA5 antibody-associated interstitial lung disease. RMD Open. 9, e003150 (2023).

Article  PubMed  Google Scholar 

Zhou, M. et al. Noninvasive positive pressure ventilator deteriorates the outcome of pneumomediastinum in anti-MDA5 antibody-positive clinically amyopathic dermatomyositis. Clin. Rheumatol. 39, 1919–1927 (2020).

Article  PubMed  Google Scholar 

Abe, K. et al. Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort study. RMD Open. 9, e002770 (2023).

Article  PubMed  Google Scholar 

Ma, X. et al. Clinical and serological features of patients with dermatomyositis complicated by spontaneous pneumomediastinum. Clin. Rheumatol. 35, 489–493 (2016).

Article  PubMed  Google Scholar 

Zhou, S. et al. Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study. Front. Immunol. 13, 928861 (2022).

Article  CAS  PubMed  Google Scholar 

Li, S. et al. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies. Clin. Rheumatol. 38, 2171–2179 (2019).

Article  PubMed  Google Scholar 

Sakamoto, R. et al. Myxovirus resistance protein 1-expressing fatal myocarditis in a patient with anti-MDA5 antibody-positive dermatomyositis. Rheumatology 60, e450–e452 (2021).

Article  PubMed  Google Scholar 

Roeser, A. et al. Successful outcome under multiple therapy in two ca